1. Home
  2. OCUL vs RLJ Comparison

OCUL vs RLJ Comparison

Compare OCUL & RLJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • RLJ
  • Stock Information
  • Founded
  • OCUL 2006
  • RLJ 2011
  • Country
  • OCUL United States
  • RLJ United States
  • Employees
  • OCUL N/A
  • RLJ N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • RLJ Real Estate Investment Trusts
  • Sector
  • OCUL Health Care
  • RLJ Real Estate
  • Exchange
  • OCUL Nasdaq
  • RLJ Nasdaq
  • Market Cap
  • OCUL 1.4B
  • RLJ 1.5B
  • IPO Year
  • OCUL 2014
  • RLJ 2011
  • Fundamental
  • Price
  • OCUL $8.01
  • RLJ $9.92
  • Analyst Decision
  • OCUL Strong Buy
  • RLJ Hold
  • Analyst Count
  • OCUL 8
  • RLJ 7
  • Target Price
  • OCUL $16.50
  • RLJ $10.92
  • AVG Volume (30 Days)
  • OCUL 874.8K
  • RLJ 1.7M
  • Earning Date
  • OCUL 03-10-2025
  • RLJ 02-25-2025
  • Dividend Yield
  • OCUL N/A
  • RLJ 5.04%
  • EPS Growth
  • OCUL N/A
  • RLJ N/A
  • EPS
  • OCUL N/A
  • RLJ 0.29
  • Revenue
  • OCUL $61,442,000.00
  • RLJ $1,359,502,000.00
  • Revenue This Year
  • OCUL $11.40
  • RLJ N/A
  • Revenue Next Year
  • OCUL $13.58
  • RLJ $2.32
  • P/E Ratio
  • OCUL N/A
  • RLJ $34.36
  • Revenue Growth
  • OCUL 6.45
  • RLJ 3.89
  • 52 Week Low
  • OCUL $3.76
  • RLJ $8.74
  • 52 Week High
  • OCUL $11.78
  • RLJ $12.39
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 38.27
  • RLJ 46.91
  • Support Level
  • OCUL $7.99
  • RLJ $9.45
  • Resistance Level
  • OCUL $8.43
  • RLJ $10.14
  • Average True Range (ATR)
  • OCUL 0.38
  • RLJ 0.22
  • MACD
  • OCUL -0.03
  • RLJ -0.02
  • Stochastic Oscillator
  • OCUL 20.66
  • RLJ 53.45

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ Lodging Trust is a real estate investment trust that acquires focused-service and compact full-service hotels. Its portfolio consists of hotels in various states across the United States and the District of Columbia. Its hotels are under the Marriott, Hilton, and Hyatt brand names. These hotels are concentrated in urban areas, dense suburban markets, and business districts within metropolitan areas. Its revenue streams include hotel operations revenue, which is composed of the sale of rooms, food, and beverages, and other property revenue. The company derives the substantial majority of its revenue from the operation of hotels.

Share on Social Networks: